Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich coiled-coil 2A (PRRC2A) is a large proline-rich protein encoded within the major histocompatibility complex III region and is highly expressed in neural cells, particularly oligodendrocyte precursor cells[1]. It functions as an N6-methyladenosine (m6A) reader protein that binds methylated mRNAs, stabilizing transcripts such as Olig2 to regulate oligodendrocyte specification and myelination by post-transcriptional mechanisms[1][3]. PRRC2A is also involved in translational regulation by promoting leaky scanning and facilitating translation of mRNAs with upstream open reading frames (uORFs)[3]. Loss of PRRC2A impairs nervous system development and is associated with neurodevelopmental defects, while genetic variants and altered expression have been reported in several cancers and autoimmune conditions[3][8]. The protein may also participate in pre-mRNA splicing and is considered essential for optimal cell proliferation[3][4]. No direct evidence supports its use as a therapeutic target, for which reason no specific drugs or mechanisms of action are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich coiled-coil 2A (PRRC2A).